Showing results (521-530 of 621) with videos related to

Sort By:
Pageof 63
Vox Sanguinis|March 23, 2026
Fundamentals of big data and artificial intelligence in transfusion medicineAmin T Turki, Christian Martin Brieske, Umut A Gurkan, et al.
Cytometry. Part B, Clinical Cytometry|November 19, 2016
Effect of ABO incompatibility on T-cell flow cytometry cross-match results prior to living donor kidney transplantationM Lindemann, V Lenz, B Nyadu, et al.
Plos One|April 9, 2015
The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patientsTiago Degani Veit, José Artur Bogo Chies, Magdalena Switala, et al.
Journal of Molecular and Cellular Cardiology|April 21, 2012
Age-related divergent remodeling of the cardiac extracellular matrix in heart failure: collagen accumulation in the young and loss in the agedMargaux A Horn, Helen K Graham, Mark A Richards, et al.
Environmental Science & Technology|April 7, 2020
Bacterial Diversity Controls Transformation of Wastewater-Derived Organic Contaminants in River-Simulating FlumesMalte Posselt, Jonas Mechelke, Cyrus Rutere, et al.
Infection|May 27, 2023
Antibody responses after sequential vaccination with PCV13 and PPSV23 in kidney transplant recipientsNils Mülling, Lukas van de Sand, Kim Völk, et al.
Journal of Virology|November 11, 2011
Escape from a dominant HLA-B*15-restricted CD8+ T cell response against hepatitis C virus requires compensatory mutations outside the epitopeMarianne Ruhl, Patrick Chhatwal, Heiko Strathmann, et al.
American Journal of Surgery|August 6, 2011
Does prehospital prolonged extrication (entrapment) place trauma patients at higher risk for venous thromboembolism?Frederick B Rogers, Sally J Hammaker, Jo Ann Miller, et al.
Viruses|January 21, 2023
Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk PatientsLaura Thümmler, Monika Lindemann, Peter A Horn, et al.
Clinical Chemistry|December 1, 2020
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 TrialSmiths S Lueong, Andreas Herbst, Sven-Thorsten Liffers, et al.
Pageof 63